Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

OXURION to Participate in Upcoming Investor Meetings

31 Mar 2021

Leuven, BE, Boston, MA, US – March 31st, 2021 – 07.30 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, today announces its management will participate and meet one on one with investors at the following upcoming virtual meetings: 

European Biotech Investor Days 2021- April 7-8, 2021 

Company Presentation, featuring Tom Graney, CFA, CFO available on demand for all registered users to view on the event’s portal. 

20th Annual Needham Healthcare Conference- April 14-15, 2021 

Company Presentation, featuring Tom Graney, CFA, CFO available on demand for all registered users to view on event’s portal. The webcasting link will be active for 90 days. 

Bio€quity Europe- May 17-19, 2021 

Company Presentation, featuring Patrik De Haes, MD, CEO available on demand for all registered users to view on event’s portal. 

Press release attachment: 
Tags: 
Investors; Company